These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27516205)

  • 1. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
    Liu YX; Wang L; Liu WJ; Zhang HT; Xue JH; Zhang ZW; Gao CJ
    J Hematol Oncol; 2016 Aug; 9(1):69. PubMed ID: 27516205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L; Wang Y; Lin J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.
    Zhao L; Li Y; Song X; Zhou H; Li N; Miao Y; Jia L
    Oncotarget; 2016 Sep; 7(37):60074-60086. PubMed ID: 27527856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
    Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-regulated STAT5A/miR-202-5p/USP15/Caspase-6 regulatory axis suppresses CML cell apoptosis and contributes to Imatinib resistance.
    Nie ZY; Yao M; Yang Z; Yang L; Liu XJ; Yu J; Ma Y; Zhang N; Zhang XY; Liu MH; Jiang LL; Luo JM
    J Exp Clin Cancer Res; 2020 Jan; 39(1):17. PubMed ID: 31952546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia.
    Wen F; Cao YX; Luo ZY; Liao P; Lu ZW
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):1-8. PubMed ID: 30366670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
    Nie ZY; Liu XJ; Zhan Y; Liu MH; Zhang XY; Li ZY; Lu YQ; Luo JM; Yang L
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MiR-124-3p Enhances the Sansitivity of Chronic Myelogenous Leukemia Cell K562-R to Imatinib by Targeting ABCA2].
    Zhang FJ; Cao WJ; Chang FF; Huang FY; Guo JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):789-796. PubMed ID: 32552937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
    Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis.
    Han Y; Ma Z
    Anticancer Drugs; 2021 Apr; 32(4):427-436. PubMed ID: 33587348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling.
    Liu X; Cui MM; Zhu HZ; Fu PY; Wang GC; Huang L
    Acta Haematol; 2022; 145(5):484-498. PubMed ID: 35313299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
    Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
    Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
    Farhadi E; Zaker F; Safa M; Rezvani MR
    Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKR1C3 decreased CML sensitivity to Imatinib in bone marrow microenvironment via dysregulation of miR-379-5p.
    Pan D; Yang W; Zeng Y; Li W; Wang K; Zhao L; Li J; Ye Y; Guo Q
    Cell Signal; 2021 Aug; 84():110038. PubMed ID: 33984486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
    Li H; Tian X; Wang P; Huang M; Xu R; Nie T
    Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circ_0080145 Enhances Imatinib Resistance of Chronic Myeloid Leukemia by Regulating miR-326/
    Che H; Ding H; Jia X
    Cancer Biother Radiopharm; 2024 Sep; 39(7):478-491. PubMed ID: 32598170
    [No Abstract]   [Full Text] [Related]  

  • 17. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.
    Yang JR; Shi MX; Zeng Y
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2103-2111. PubMed ID: 30915755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic β cells via the inhibition of SOCS3.
    Li Y; Luo T; Wang L; Wu J; Guo S
    Int J Mol Med; 2016 Nov; 38(5):1515-1524. PubMed ID: 27666763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of SOCS3 mRNA in bone marrow cells from CML patients associated with cytogenetic response to IFN-alpha.
    Takeuchi K; Sakai I; Narumi H; Yasukawa M; Kojima K; Minamoto Y; Fujisaki T; Tanimoto K; Hara M; Numata A; Gondo H; Takahashi M; Fujii N; Masuda K; Fujita S
    Leuk Res; 2005 Feb; 29(2):173-8. PubMed ID: 15607366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
    Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.